Previous studies have reported that IGF2BP3 plays oncogenic roles by activating PI3K/AKT pathway in colorectal cancer (Zhang et al., 2020), Ewing sarcoma (Mancarella et al., 2018), and glioblastoma (Suvasini et al., 2011). Here, AKT1 is linked to Ewing sarcoma.